ferrous sulfate 137 MG Extended Release Oral Tablet
Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.
Start free with EleplanClinical drug
ferrous sulfate 137 MG Extended Release Oral Tablet
137 MG · Extended Release Oral Tablet · oral
A form of ferrous →
ferrous sulfate 137 MG Extended Release Oral Tablet. Strength, form, class, interactions & more.
Active ingredient
Drug interactions
The label outlines various drug interactions with combined oral contraceptives (COCs) that may affect their efficacy and plasma concentrations.
- majorCYP3A4 inducers — may decrease the effectiveness of COCs or increase breakthrough bleeding
- majorphenytoin — may decrease the effectiveness of COCs
- majorbarbiturates — may decrease the effectiveness of COCs
- majorcarbamazepine — may decrease the effectiveness of COCs
- majorbosentan — may decrease the effectiveness of COCs
- majorfelbamate — may decrease the effectiveness of COCs
- majorgriseofulvin — may decrease the effectiveness of COCs
- majoroxcarbazepine — may decrease the effectiveness of COCs
- majorrifampicin — may decrease the effectiveness of COCs
- majortopiramate — may decrease the effectiveness of COCs
- majorrifabutin — may decrease the effectiveness of COCs
- majorrufinamide — may decrease the effectiveness of COCs
- majoraprepitant — may decrease the effectiveness of COCs
- majorSt. John’s wort — may decrease the effectiveness of COCs
- majorcolesevelam — significantly decreases the AUC of EE
- moderateatorvastatin — increases AUC values for EE
- moderaterosuvastatin — increases AUC values for EE
- moderateascorbic acid — may increase plasma EE concentrations
- moderateacetaminophen — may increase plasma EE concentrations
- moderateCYP3A4 inhibitors — may increase plasma hormone concentrations
- moderateHIV protease inhibitors — significant changes in plasma concentrations of estrogen and/or progestin
- moderateHCV protease inhibitors — significant changes in plasma concentrations of estrogen and/or progestin
- majorlamotrigine — may reduce seizure control
- moderatethyroid hormone — may need increased doses of thyroid hormone
- majorombitasvir/paritaprevir/ritonavir — potential for ALT elevations
Source: RxNorm + openFDA + RxClass + FAERS · 2026
Look up another medication